Company Registration No. 05499009 (England and Wales)
ALVOS ONCOLOGY LIMITED
UNAUDITED ABBREVIATED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2015
ALVOS ONCOLOGY LIMITED
CONTENTS
Page
Abbreviated balance sheet
1
Notes to the abbreviated accounts
2 - 3
ALVOS ONCOLOGY LIMITED
ABBREVIATED BALANCE SHEET
AS AT
31 JULY 2015
31 July 2015
- 1 -
2015
2014
Notes
£
£
£
£
Fixed assets
Tangible assets
2
303
266
Investments
2
11,706
17,211
12,009
17,477
Current assets
Debtors
2,199
403
Cash at bank and in hand
96,005
73,833
98,204
74,236
Creditors: amounts falling due within one year
(6,190)
(3,754)
Net current assets
92,014
70,482
Total assets less current liabilities
104,023
87,959
Capital and reserves
Called up share capital
3
1
1
Profit and loss account
104,022
87,958
Shareholders' funds
104,023
87,959
For the financial year ended 31 July 2015 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
-
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
-
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These abbreviated financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
Approved by the Board for issue on 18 March 2016
Dr R Burns
Director
Company Registration No. 05499009
ALVOS ONCOLOGY LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31 JULY 2015
- 2 -
1
Accounting policies
1.1
Accounting convention
The financial statements are prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (effective April 2008).
1.2
Compliance with accounting standards
The financial statements are prepared in accordance with applicable United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), which have been applied consistently (except as otherwise stated).
1.3
Turnover
Turnover represents amounts receivable for consultancy services net of VAT and discounts.
1.4
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost less estimated residual value of each asset over its expected useful life, as follows:
Fixtures, fittings & equipment
25% Reducing balance
1.5
Investments
Fixed asset investments are stated at cost less provision for diminution in value.
2
Fixed assets
Tangible assets
Investments
Total
£
£
£
Cost
At 1 August 2014
1,772
17,211
18,983
Additions
139
2,840
2,979
Disposals
-
(8,345)
(8,345)
At 31 July 2015
1,911
11,706
13,617
Depreciation
At 1 August 2014
1,506
-
1,506
Charge for the year
102
-
102
At 31 July 2015
1,608
-
1,608
Net book value
At 31 July 2015
303
11,706
12,009
At 31 July 2014
266
17,211
17,477
ALVOS ONCOLOGY LIMITED
NOTES TO THE ABBREVIATED ACCOUNTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2015
- 3 -
3
Share capital
2015
2014
£
£
Allotted, called up and fully paid
1 Ordinary shares of £1 each
1
1